Literature DB >> 17901547

Role of liver and plasma lipoproteins in selective transport of n-3 fatty acids to tissues: a comparative study of 14C-DHA and 3H-oleic acid tracers.

Alla Polozova1, Norman Salem.   

Abstract

We conducted a study aimed at a direct comparison of the plasma dynamics and uptake of docosahexaenoic (DHA) and oleic (OA) fatty acids by various organs. 14C-DHA and 3H-OA were intravenously co-injected into mice. At 5 min after injection, more than 40% of the 14C-DHA, but less than 20% of the 3H-OA, labels was associated with the liver. Heart uptake of 14C-DHA was three to four times greater compared to the 3H-OA label. Brain incorporation of 14C-DHA slowly rose to 0.7% at 24 h, but it remained at the 1-1.5% level for 3H-OA. Total 14C activity in plasma reached 2% of the injected dose at 20 min and leveled off at 0.5% after 1.5 h. Fifteen percent of 14C-DHA plasma activity at 30 min was associated with non-esterified fatty acids, whereas about 85% was recovered in triglycerides in very low-density lipoprotein (VLDL) and LDL fractions. Only 30% of 3H-OA derived activity was found in the VLDL fraction at 30 min. All 3H activity in plasma at later time points was in catabolite fractions. These findings demonstrate that liver plays an important role in the initial selectivity for DHA. It is likely that DHA is specifically taken up by liver, esterified, loaded into lipoproteins, and then delivered to brain, heart, and other target tissues.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901547     DOI: 10.1007/s12031-007-0039-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  68 in total

Review 1.  Diverse roles for the LDL receptor family.

Authors:  Dudley K Strickland; Steven L Gonias; W Scott Argraves
Journal:  Trends Endocrinol Metab       Date:  2002-03       Impact factor: 12.015

2.  Separation of lipid classes by high-performance liquid chromatography with the "mass detector".

Authors:  W W Christie
Journal:  J Chromatogr       Date:  1986-06-27

3.  Palmitate and cholesterol transport through the blood-brain barrier.

Authors:  W M Pardridge; L J Mietus
Journal:  J Neurochem       Date:  1980-02       Impact factor: 5.372

4.  Very long chain n-3 and n-6 polyunsaturated fatty acids bind strongly to liver fatty acid-binding protein.

Authors:  Andrew W Norris; Arthur A Spector
Journal:  J Lipid Res       Date:  2002-04       Impact factor: 5.922

5.  The fatty acid composition of human gliomas differs from that found in nonmalignant brain tissue.

Authors:  D D Martin; M E Robbins; A A Spector; B C Wen; D H Hussey
Journal:  Lipids       Date:  1996-12       Impact factor: 1.880

6.  ABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells.

Authors:  Ute Panzenboeck; Zoltan Balazs; Andrea Sovic; Andelko Hrzenjak; Sanja Levak-Frank; Andrea Wintersperger; Ernst Malle; Wolfgang Sattler
Journal:  J Biol Chem       Date:  2002-08-28       Impact factor: 5.157

7.  Placental membrane fatty acid-binding protein preferentially binds arachidonic and docosahexaenoic acids.

Authors:  F M Campbell; M J Gordon; A K Dutta-Roy
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

Review 8.  LDL receptor relatives at the crossroad of endocytosis and signaling.

Authors:  W J Schneider; J Nimpf
Journal:  Cell Mol Life Sci       Date:  2003-05       Impact factor: 9.261

9.  Essential fatty acid metabolism in the feline: relationship between liver and brain production of long-chain polyunsaturated fatty acids.

Authors:  R Pawlosky; A Barnes; N Salem
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

10.  A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier.

Authors:  B Dehouck; L Fenart; M P Dehouck; A Pierce; G Torpier; R Cecchelli
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

View more
  14 in total

Review 1.  Dietary omega 3 polyunsaturated fatty acids and Alzheimer's disease: interaction with apolipoprotein E genotype.

Authors:  P Barberger-Gateau; C Samieri; C Féart; M Plourde
Journal:  Curr Alzheimer Res       Date:  2011-08       Impact factor: 3.498

2.  GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects.

Authors:  Da Young Oh; Saswata Talukdar; Eun Ju Bae; Takeshi Imamura; Hidetaka Morinaga; WuQiang Fan; Pingping Li; Wendell J Lu; Steven M Watkins; Jerrold M Olefsky
Journal:  Cell       Date:  2010-09-03       Impact factor: 41.582

3.  Acute injection of a DHA triglyceride emulsion after hypoxic-ischemic brain injury in mice increases both DHA and EPA levels in blood and brain.

Authors:  Denny Joseph Manual Kollareth; Richard J Deckelbaum; Zequn Liu; Rajasekhar Ramakrishnan; Charlotte Jouvene; Charles N Serhan; Vadim S Ten; Hylde Zirpoli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-25       Impact factor: 4.006

4.  Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats.

Authors:  Johnny D Figueroa; Kathia Cordero; Keisha Baldeosingh; Aranza I Torrado; Robert L Walker; Jorge D Miranda; Marino De Leon
Journal:  J Neurotrauma       Date:  2011-11-07       Impact factor: 5.269

5.  Fasting enriches liver triacylglycerol with n-3 polyunsaturated fatty acids: implications for understanding the adipose-liver axis in serum docosahexaenoic acid regulation.

Authors:  Kristin A Marks; Phillip M Marvyn; Juan J A Henao; Ryan M Bradley; Ken D Stark; Robin E Duncan
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

Review 6.  Inflammation and lipid signaling in the etiology of insulin resistance.

Authors:  Christopher K Glass; Jerrold M Olefsky
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

Review 7.  Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.

Authors:  Hussein N Yassine; Meredith N Braskie; Wendy J Mack; Katherine J Castor; Alfred N Fonteh; Lon S Schneider; Michael G Harrington; Helena C Chui
Journal:  JAMA Neurol       Date:  2017-03-01       Impact factor: 18.302

Review 8.  Role of n-3 Polyunsaturated Fatty Acids in Ameliorating the Obesity-Induced Metabolic Syndrome in Animal Models and Humans.

Authors:  Chao-Wei Huang; Yi-Shan Chien; Yu-Jen Chen; Kolapo M Ajuwon; Harry M Mersmann; Shih-Torng Ding
Journal:  Int J Mol Sci       Date:  2016-10-09       Impact factor: 5.923

9.  APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer's Disease.

Authors:  Laila Abdullah; James E Evans; Tanja Emmerich; Gogce Crynen; Ben Shackleton; Andrew P Keegan; Cheryl Luis; Leon Tai; Mary J LaDu; Michael Mullan; Fiona Crawford; Corbin Bachmeier
Journal:  Aging (Albany NY)       Date:  2017-03-23       Impact factor: 5.682

10.  A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.

Authors:  Da Young Oh; Evelyn Walenta; Taro E Akiyama; William S Lagakos; Denise Lackey; Ariane R Pessentheiner; Roman Sasik; Nasun Hah; Tyler J Chi; Jason M Cox; Mary Ann Powels; Jerry Di Salvo; Christopher Sinz; Steven M Watkins; Aaron M Armando; Heekyung Chung; Ronald M Evans; Oswald Quehenberger; Joanne McNelis; Juliane G Bogner-Strauss; Jerrold M Olefsky
Journal:  Nat Med       Date:  2014-07-06       Impact factor: 87.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.